Author:
Aliforenko A. E.,Motov V. S.,Bykov V. V.,Bykova A. V.,Pavlovsky V. I.,Larchenko V. V.,Khazanov V. A.,Vengerovskii A. I.
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Gonçalves ECD, Vieira G, Gonçalves TR, Simões RR, Brusco I, Oliveira SM, Calixto JB, Cola M, Santos ARS, Dutra RC. Bradykinin receptors play a critical role in the chronic post-ischaemia pain model. Cell Mol. Neurobiol. 2021;41(1):63-78. doi: https://doi.org/10.1007/s10571-020-00832-3
2. Litvitsky PP. Inflammation. Vopr. Sovrem. Pediatr. 2006;5(4):75-81. Russian.
3. Marceau F, Bachelard H, Bouthillier J, Fortin JP, Morissette G, Bawolak MT, Charest-Morin X, Gera L. Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. Int. Immunopharmacol. 2020;82:106305. doi: https://doi.org/10.1016/j.intimp.2020.106305
4. Andronati SA, Pavlovsky VI, Golovenko MYa, Reder AS, Larionov VB, Valivodz’ IP. Synthesis and extraction efficiency from biological fluids of [214C]Propoxazepam: a potent analgesic with multifunctional mechanism of action. JCBPS. Section A. 2019;9(4):323-333. doi: https://doi.org/10.24214/jcbps.A.9.4.32333
5. Pavlovskij VI, Khazanov VA, Stankevich SA. Patent RU No. 2701557. 1,4-Benzodiazepin-2-one derivatives and use thereof. Bull. No. 15. Published September 30, 2019.